February 9, 2021 11:03 pm
Original Link: https://www.theverge.com/22274371/covid-vaccine-astrazeneca-south-africa-variant
AstraZenecas COVID-19 vaccine has been confusing from the start
South Africa announced this week that it’s stopping the use of the AstraZeneca-Oxford COVID-19 vaccine after a small study found that it wasn’t effective against mild and moderate disease. Other vaccines are also less effective in South Africa, where a variant of the virus with mutations that can dodge antibodies is circulating widely. The AstraZeneca-Oxford product appears to be the worst of all, and it fell down to less than 50 percent effective (the benchmark health agencies set for COVID-19 vaccines).
It’s another hit for the AstraZeneca-Oxford vaccine, which has been dogged by shaky relationships with regulators and limited transparency for months. But it’s also a confusing result: the small trial wasn’t able to figure out if the...
Original Link: https://www.theverge.com/22274371/covid-vaccine-astrazeneca-south-africa-variant
Share this article:
Tweet
View Full Article
The Verge
The Verge is an ambitious multimedia effort founded in 2011More About this Source Visit The Verge